Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2021 07:00 ET | Source: Applied Genetic Technologies Corporation

AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2021

-Company on track to provide multiple data readouts for XLRP and ACHM clinical programs in 2021 and 2022- -Company to host management update and webcast today at 8:00 a.m. ET- GAINESVILLE,...
November 02, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 9, 2021

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
October 19, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Present at Upcoming Dry AMD Therapeutic Development Summit

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
October 14, 2021 17:00 ET | Source: Applied Genetic Technologies Corporation

AGTC Announces Two Key Leadership Team Appointments

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
October 12, 2021 11:08 ET | Source: Applied Genetic Technologies Corporation

AGTC to Present at Upcoming Cell & Gene Meeting on the Mesa

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
October 12, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Present at Upcoming Cell & Gene Management Meeting on the Mesa

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
September 28, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC Clinical Trial Investigators to Present Data from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Fourteenth International Symposium on Retinal Degeneration

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
September 27, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
September 23, 2021 16:05 ET | Source: Applied Genetic Technologies Corporation

AGTC Provides Financial Results for the Fourth Quarter and Year Ended June 30, 2021

-Data from ongoing clinical trials in XLRP and ACHM shows evidence of clinical activity and tolerability; multiple data readouts expected in 2021 and 2022- -Pre-Clinical programs moving to IND...
September 16, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Host Fourth Quarter and 2021 Fiscal Year End Financial Results Conference Call and Webcast on September 23, 2021

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...